Cash Flow

v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Cash Flows From Operating Activities:      
Net loss $ (12,536,638) $ (10,384,953) $ (8,295,698)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 779,701 986,620 732,151
(Gain) loss on revaluation of derivative warrant liability   (452,147) 838,219
Gain on extinguishment of liability (450,000)
Issuance of common stock for services and release agreements 377,200 704,019 150,000
Fair value of options issued to purchase units of common stock 104,138
Warrants issued and repriced in settlement agreements 190,890
Non-cash interest expense 762,078
Depreciation 1,753 2,632 1,343
Write-off of abandoned trademarks 5,401
Changes in operating assets and liabilities:      
Other receivables (818,343)
Prepaid expenses 162,514 572,098 (40,759)
Accounts payable 971,013 (306,725) 105,230
Accrued expenses 70,739 (397,183) 351,182
Accrued compensation 135,915 159,750 288,250
Accrued interest - related parties 15,645 87,578 7,009
Due to related party (27,637) (42,749)
Net Cash Used In Operating Activities (11,318,138) (7,971,205) (5,900,421)
Cash Flows From Investing Activities:      
Cash acquired in acquisition 255,748
Purchase of property and equipment (2,126)
Net Cash Provided By (Used In) Investing Activities (2,126) 255,748
Cash Flows From Financing Activities:      
Proceeds from notes payable - related parties 4,210,000 500,000
Repayment of notes payable - related parties (600,000)
Proceeds from common stock warrant exercises 1,125,148
Proceeds from stock option exercise 40
Net proceeds from common stock and warrants in August 2018 offering 8,926,786
Net proceeds from registered direct offering 7,246,099
Net proceeds from private placement 556,152 5,427,688
Net proceeds from public offering   6,116,896  
Deferred offering costs (64,801)
Net Cash Provided By Financing Activities 17,298,033 10,883,088 5,262,887
Increase (Decrease) in Cash and Cash Equivalents 5,979,895 2,909,757 (381,786)
Cash and Cash Equivalents - Beginning of Year 3,204,108 294,351 676,137
Cash and Cash Equivalents - End of Year 9,184,003 3,204,108 294,351
Supplemental Disclosures of Cash Flow Information and Non-cash Transactions:      
Interest paid 193 1,133 1,985
Premium on convertible promissory notes - related party 833,333
Fair value of unit purchase option issued for future services 193,860
Fair value of warrants issued for future services 477,181
Reclassification of derivative warrant liability to additional paid-in capital 1,229,826 1,093,765
Beneficial conversion feature on convertible promissory notes - related party   1,595,411  
Conversion of convertible promissory notes – related party and related accrued interest into common stock 4,786,240
Par value of common stock issued upon cashless exercise of warrants $ 17

Source